Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
MDA-MB-231 Abemaciclib
0.0031623
CDK4/6
Cell cycle
0.8583 0.00282
MDA-MB-231 Abemaciclib
0.01
CDK4/6
Cell cycle
0.7012 -0.00059
MDA-MB-231 Abemaciclib
0.031623
CDK4/6
Cell cycle
0.4981 0.00329
MDA-MB-231 Abemaciclib
0.1
CDK4/6
Cell cycle
0.2911 0.03747
MDA-MB-231 Abemaciclib
0.31623
CDK4/6
Cell cycle
0.1512 0.05085
MDA-MB-231 Abemaciclib
1.0
CDK4/6
Cell cycle
0.0712 0.11638
MDA-MB-231 Abemaciclib
3.1623
CDK4/6
Cell cycle
-0.1904 0.37030
MDA-MB-231 Abemaciclib
10.0
CDK4/6
Cell cycle
-0.4875 0.66697
MDA-MB-231 Palbociclib
0.00031623
CDK4/6
Cell cycle
1.0771 0.00134
MDA-MB-231 Palbociclib
0.001
CDK4/6
Cell cycle
0.9933 0.00405
MDA-MB-231 Palbociclib
0.0031623
CDK4/6
Cell cycle
0.9194 -0.00272
MDA-MB-231 Palbociclib
0.01
CDK4/6
Cell cycle
0.8221 -0.00579
MDA-MB-231 Palbociclib
0.031623
CDK4/6
Cell cycle
0.6564 -0.00354
MDA-MB-231 Palbociclib
0.1
CDK4/6
Cell cycle
0.5015 0.00933
MDA-MB-231 Palbociclib
0.31623
CDK4/6
Cell cycle
0.4172 0.01567
MDA-MB-231 Palbociclib
1.0
CDK4/6
Cell cycle
0.2865 0.03314
MDA-MB-231 Palbociclib
3.1623
CDK4/6
Cell cycle
0.2066 0.03980
MDA-MB-231 AZD7762
0.001
CHK1/2
Cell cycle
1.0672 0.00807
MDA-MB-231 AZD7762
0.0031623
CHK1/2
Cell cycle
1.0685 0.00985
MDA-MB-231 AZD7762
0.01
CHK1/2
Cell cycle
1.1122 0.02829
MDA-MB-231 AZD7762
0.031623
CHK1/2
Cell cycle
0.9306 0.06651
MDA-MB-231 AZD7762
0.1
CHK1/2
Cell cycle
0.5084 0.18185
MDA-MB-231 AZD7762
0.31623
CHK1/2
Cell cycle
0.2822 0.24126
MDA-MB-231 AZD7762
1.0
CHK1/2
Cell cycle
-0.0553 0.35599
MDA-MB-231 AZD7762
3.1623
CHK1/2
Cell cycle
-0.3630 0.59853